Entity
  • IABS - International Alliance for Biological Standardization

    Created in 1955
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    1,991
  • Activities

  • Entity types

  • Location

    Rue Mina-AUDEMARS 3/1204, 1204 Genève, Switzerland

    Genève

    Switzerland

  • Employees

    Scale: 201-500

    Estimated: 9

  • Engaged corporates

    5
    1 4
  • Added in Motherbase

    1 year, 3 months ago
Description
  • Value proposition

    A neutral platform for Regulatory consensus creation in the field
    of Human and Veterinary biologicals

    The International Alliance for Biological Standardization is an independent, nonprofit scientific organization located in Geneva, Switzerland with about 250 members in over 50 countries. Operational offices are in Lyon, France.
    IABS vision: Health Solutions for everyone everywhere.
    IABS missions:
    #1 To bring biologicals stakeholders together
    Our strength is to bring together private industry, academia and regulatory agencies to conduct scientific discussions on a global scale.
    #2 To facilitate consensus
    Our collaborative events, such as conferences and workshops, guide decision-making and accelerate the standardization of biological products.
    #3 To share scientific advancements
    We contribute to the improvement and innovation of biological products, through our Journal Biologicals and the website .
    IABS' role and strength reside in its ability to bring together interested parties for scientific discussions of important unresolved or emerging issues and to assist in developing a consensus with an action plan to achieve regulatory progress. This strategy has led to significant gains in both the human and veterinary fields, and it differentiates lABS conferences from most scientific meetings that focus simply on the exchange of information. Our activities contribute to faster global access to new vaccines for human and animal health. We have worked successfully with, and have supplemented the activities of, WH0, FDA, USDA, NIAID, EMA, and OIE.
    For more information, please visit our website at www.iabs.org

    Biological, Vaccines, Regulatory, Standardization, Biotherapeutics, blood products, Cell and Gene therapies, Veterinary biologicals, and Regulatory sciences

Corporate interactions BETA
Corporate TypeTweets Articles
Moderna
Moderna
Pharmaceutical, Biotechnology, Biotechnology Research
Moderna
Pharmaceutical, Biotechnology, Biotechnology Research
Other

30 Nov 2024


Bristol Myers Squibb
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Other

30 Nov 2024


Pfizer
Pfizer
Pharmaceutical, Pharmaceutical Manufacturing
Pfizer
Pharmaceutical, Pharmaceutical Manufacturing
Other

30 Nov 2024


Boehringer Ingelheim
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
Other

30 Nov 2024


CEVA SANTE ANIMALE
CEVA SANTE ANIMALE
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
CEVA SANTE ANIMALE
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
Other

30 Oct 2024


Similar entities
Loading...
Loading...
Social network dynamics